Racura Oncology Ltd (ASX:RAC)

Racura Oncology Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	13.67	17.19	21.52	33.54	9.32
Cash & Short-Term Investments	13.67	17.19	21.52	33.54	9.32
Cash Growth	-20.50%	-20.13%	-35.84%	259.79%	438.63%
Other Receivables	0.03	0.11	1.7	0.06	0.13
Receivables	0.03	0.11	1.7	0.06	0.13
Prepaid Expenses	1.26	0.12	0.32	0.55	1.14
Total Current Assets	14.96	17.42	23.54	34.15	10.59
Other Intangible Assets	2.53	2.81	3.09	3.37	3.66
Total Assets	17.49	20.23	26.64	37.52	14.25
Accounts Payable	0.46	1.2	0.64	0.83	0.31
Accrued Expenses	0.97	0.67	0.51	0.58	0.21
Other Current Liabilities	0.02	-	-	-	-
Total Current Liabilities	1.45	1.87	1.15	1.42	0.52
Other Long-Term Liabilities	0.02	0.05	-	-	-
Total Liabilities	1.48	1.92	1.15	1.42	0.52
Common Stock	68.49	66.95	61.71	62.02	31.5
Retained Earnings	-62.21	-57.42	-43.6	-33.68	-22.47
Comprehensive Income & Other	9.73	8.78	7.38	7.77	4.69
Shareholders' Equity	16.01	18.31	25.49	36.11	13.72
Total Liabilities & Equity	17.49	20.23	26.64	37.52	14.25
Net Cash (Debt)	13.67	17.19	21.52	33.54	9.32
Net Cash Growth	-20.50%	-20.13%	-35.84%	259.79%	438.63%
Net Cash Per Share	0.08	0.10	0.13	0.22	0.07
Filing Date Shares Outstanding	173.74	170.39	163.07	159.52	144.4
Total Common Shares Outstanding	173.74	170.3	163.07	159.52	143.65
Working Capital	13.51	15.55	22.39	32.73	10.07
Book Value Per Share	0.09	0.11	0.16	0.23	0.10
Tangible Book Value	13.48	15.5	22.39	32.73	10.07
Tangible Book Value Per Share	0.08	0.09	0.14	0.21	0.07

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.